0.0520
-0.0010
(-1.89%)
At close: 2:01:14 PM GMT+10
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Cash Flows from Used in Operating Activities Direct
-5,127.1820
-5,127.1820
-5,289.6880
-4,402.0190
-2,916.2550
Investing Cash Flow
-2.2260
-2.2260
-58.4250
-26.6420
-5.3470
Financing Cash Flow
-772.9810
-772.9810
-84.2170
17,189.0210
3,663.3060
End Cash Position
3,385.3100
3,385.3100
9,256.6770
14,608.5810
1,848.4080
Capital Expenditure
-2.2260
-2.2260
-17.6310
-14.4020
-5.3470
Issuance of Capital Stock
0.2410
0.2410
21.2330
16,270.8840
4,063.5640
Issuance of Debt
1,467
1,467
--
2,100
--
Repayment of Debt
-2,100
-2,100
--
--
--
Repurchase of Capital Stock
--
--
--
-1,181.8630
-400.2580
Free Cash Flow
-5,129.4080
-5,129.4080
-5,307.3190
-4,416.4210
-2,921.6020
3/31/2021 - 1/12/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
BTC.AX BTC Health Limited
0.0460
-8.00%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
RNV.AX RENERVE FPO [RNV]
0.1100
+4.76%
1AI.AX Algorae Pharmaceuticals Limited
0.0060
+20.00%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
TRP.AX Tissue Repair Ltd
0.2400
0.00%
CMB.AX Cambium Bio Limited
0.3000
+7.14%
BGT.AX Bio-Gene Technology Limited
0.0310
0.00%